The economic impacts of using adalimumab (Humira® ) for reducing pain in people with ankylosing spondylitis: A microsimulation study for Australia.
Deborah SchofieldRupendra ShresthaMichelle CunichPublished in: International journal of rheumatic diseases (2018)
Adalimumab therapy generates substantial economic benefits in addition to health benefits for individuals, and savings for government.